Gene & Cell Therapy Focused CRO/CDMO
OBiO Technology (688238.SH) is a gene and cell therapy-focused CRO & CDMO founded in 2013. In China for global customers, we offer holistic research, development, and manufacturing solutions for vectorology studies, functional genomics, process and analytical development, IND-enabling CMC, clinical and commercial manufacturing. With "enable gene therapy for better lives" as our mission, we are committed to providing high-quality service to global customers, advancing your product from bench to clinic, and bringing benefit to populations around the world.
Brands: Cell Line Development, Bank Construction, Process Development, Stability Studies, IND-Enabling CMC, Clinical Manufacturing, Commerical Manufacturing